We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants (NIV NAVA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01624012
First Posted: June 20, 2012
Last Update Posted: May 12, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Merja Ålander, University of Oulu
  Purpose

The purpose of this study is to compare if a new noninvasive ventilation mode (NIV NAVA) is better in noninvasive ventilation of premature infants than currently used Nasal Continuous Airway Pressure (ncpap), and if NIV NAVA gives real benefits for patients or not.

The investigators study hypothesis is that with NIV NAVA the invasive ventilation is more synchronous with patient, which will lead to a decrease in need of inspired oxygen.


Condition Intervention
Respiratory Distress Syndrome (RDS) of Neonate Device: NIV NAVA Device: Nasal continuous positive airway pressure

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist (NIV NAVA) Versus Nasal Continuous Airway Pressure (NCPAP) in Premature Infants

Resource links provided by NLM:


Further study details as provided by Merja Ålander, University of Oulu:

Primary Outcome Measures:
  • Duration of inspired oxygen supply [ Time Frame: 30minutes- 3weeks ]
    Participants will be followed for the duration of hospital stay, an expected average of 3 weeks


Secondary Outcome Measures:
  • Duration of noninvasive ventilation [ Time Frame: 30 minutes - 3 weeks ]
    Participants will be followed for the duration of hospital stay, an expected average of 3 weeks

  • Fraction of inspired oxygen [ Time Frame: 0, 1, 3 and 6hours, after which every 6 hours ]
    Participants will be followed for the duration of hospital stay, an expected average of 3 weeks

  • Blood gas analyses [ Time Frame: 3 weeks ]
    Participants will be followed for the duration of hospital stay, an expected average of 3 weeks.

  • Duration of parenteral nutrition [ Time Frame: 3 weeks ]
    Participants will be followed for the duration of hospital stay, an expected average of 3 weeks


Enrollment: 40
Study Start Date: August 2011
Study Completion Date: May 2016
Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: NIV NAVA
Noninvasive ventilation in this group is practiced with NIV NAVA
Device: NIV NAVA
Non invasive ventilation with neurally adjusted ventilatory assist
Active Comparator: ncpap
Patients randomized to this arm will receive noninvasive ventilation with continuous nasal CPAP as routinely in neonatal intensive care unit.
Device: Nasal continuous positive airway pressure
Noninvasive respiratory support with continuous positive airway pressure

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 48 Hours   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • postconceptional age 28+0 - 36+6
  • need of ncpap treatment and inspired oxygen for at least 60 minutes

Exclusion Criteria:

  • severe birth asphyxia, malformation or chromosomal abnormality, or other condition, which will decrease life expectancy
  • any condition which prevents insertion of naso/orogastric tube
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01624012


Locations
Finland
Oulu University hospital
Oulu, Finland, 90230
Sponsors and Collaborators
University of Oulu
  More Information

Responsible Party: Merja Ålander, Principal investigator, University of Oulu
ClinicalTrials.gov Identifier: NCT01624012     History of Changes
Other Study ID Numbers: EETTMK:23/2011
First Submitted: June 4, 2012
First Posted: June 20, 2012
Last Update Posted: May 12, 2016
Last Verified: May 2016

Keywords provided by Merja Ålander, University of Oulu:
NIV NAVA
non-invasive ventilation

Additional relevant MeSH terms:
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases